Group 1 - Zealand Pharma will participate in the 44th J.P. Morgan Healthcare Conference from January 12-15, 2026, in San Francisco, California [1] - Adam Steensberg, President and CEO, will present and engage in a fireside chat on January 14 at 1:30 PM PST / 10:30 PM CET, with a live audio webcast available [2] - The company focuses on advancing medicines for obesity and metabolic health, leveraging over 25 years of peptide R&D expertise and a proprietary data platform utilizing advanced data-driven and AI/ML approaches [3] Group 2 - More than ten drug candidates invented by Zealand Pharma have entered clinical development, with two products already on the market and three candidates in late-stage development [4] - Zealand Pharma was founded in 1998 and is headquartered in Copenhagen, Denmark, with a U.S. presence in Boston, Massachusetts [4]
Zealand Pharma to present at the J.P. Morgan Healthcare Conference
Globenewswire·2026-01-05 16:05